Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples